LMLaura E. Martin

Laura E. Martin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Laura E. Martin has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Neuroimaging as a Tool for Advancing Pediatric Psychopharmacology

    by Michael Bartkoski, John Tumberger, Laura Martin, In-Young Choi, Phil Lee, Jeffrey R. Strawn, William M. Brooks, Stephani L. Stancil

    Neuroimaging, specifically magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), and positron emission tomography (PET), plays an important role in improving the therapeutic landscape of pediatric neuropsychopharmacology by detecting target engagement, pathway modulation, and disease-related changes in the brain. This review provides a comprehensive update on the application of neuroimaging to detect neural effects of psychotropic medication in pediatrics. Additionally, we discuss opportunities and challenges for expanding the use of neuroimaging to advance pediatric neuropsychopharmacology. PubMed and Embase were searched for studies published between 2012 and 2024 reporting neural effects of attention deficit hyperactivity disorder (ADHD) medications (e.g., methylphenidate, amphetamine, atomoxetine, guanfacine), selective serotonin reuptake inhibitors (e.g., fluoxetine, escitalopram, sertraline), serotonin/norepinephrine reuptake inhibitors (e.g., duloxetine, venlafaxine), second-generation antipsychotics (e.g., aripiprazole, olanzapine, risperidone, quetiapine, ziprasidone), and others (e.g., lithium, carbamazepine, lamotrigine, ketamine, naltrexone) used to treat pediatric psychiatric conditions. Of the studies identified (N = 57 in 3314 pediatric participants), most (86%, total participants n = 3045) used MRI to detect functional pathway modulation or anatomical changes. Fewer studies (14%, total participants n = 269) used MRS to understand neurochemical modulation. No studies used PET. Studies that included healthy controls detected normalization of disease-altered pathways following treatment. Studies that focused on affected youth detected neuromodulation following single-dose and ongoing treatment. Neuroimaging is positioned to serve as a biomarker capable of demonstrating acute brain modulation, predicting clinical response, and monitoring disease, yet biomarker validation requires further work. Neuroimaging is also well suited to fill the notable knowledge gap of long-term neuromodulatory effects of psychotropic medications in the context of ongoing brain development in children and adolescents. Future studies can leverage advancements in neuroimaging technology, acquisition, and analysis to fill these gaps and accelerate the discovery of novel therapeutics, leading to more effective prescribing and ensuring faster recovery.


  • Pregnancy as a window of opportunity for dementia prevention: a narrative review

    by Lauren K. Hand, Matthew K. Taylor, Debra K. Sullivan, Catherine F. Siengsukon, Jill K. Morris, Laura E. Martin, Holly R. Hull

    Dementia is a debilitating condition with a disproportionate impact on women. While sex differences in longevity contribute to the disparity, the role of the female sex as a biological variable in disease progression is not yet fully elucidated. Metabolic dysfunctions are drivers of dementia etiology, and cardiometabolic diseases are among the most influential modifiable risk factors. Pregnancy is a time of enhanced vulnerability for metabolic disorders. Many dementia risk factors, such as hypertension or blood glucose dysregulation, often emerge for the first time in pregnancy. While such cardiometabolic complications in pregnancy pose a risk to the health trajectory of a woman, increasing her odds of developing type 2 diabetes or chronic hypertension, it is not fully understood how this relates to her risk for dementia. Furthermore, structural and functional changes in the maternal brain have been reported during pregnancy suggesting it is a time of neuroplasticity for the mother. Therefore, pregnancy may be a window of opportunity to optimize metabolic health and support the maternal brain. Healthy dietary patterns are known to reduce the risk of cardiometabolic diseases and have been linked to dementia prevention, yet interventions targeting cognitive function in late life have largely been unsuccessful. Earlier interventions are needed to address the underlying metabolic dysfunctions and potentially reduce the risk of dementia, and pregnancy offers an ideal opportunity to intervene. This review discusses current evidence regarding maternal brain health and the potential window of opportunity in pregnancy to use diet to address neurological health disparities for women.

  • Open Access

    Testing and Optimizing Guided Thinking Tasks to Promote Physical Activity: Protocol for a Randomized Factorial Trial

    by Austin S Baldwin, Colin L Lamb, Bree A Geary, Alexis D Mitchell, Chrystyna D Kouros, Sara Levens, Laura E Martin

    Background: Insufficient physical activity is associated with various health risks; however, most current physical activity interventions have critical barriers to scalability. Delivering interventions via technology and identifying active and inert components in early-phase development are ways to build more efficient and scalable interventions. We developed a novel intervention to promote physical activity that targets 3 brief guided thinking tasks, separately and in combination, using brief audio recordings: (1) episodic future thinking (EFT), (2) positive affective imagery (PAI), and (3) planning. Objective: The aim of this GeT (Guided Thinking) Active study is to optimize a scalable guided thinking intervention to promote physical activity using principles of the Multiphase Optimization Strategy (MOST). Mechanism-focused analyses will inform which components are optimal candidates for inclusion in an intervention package and which need refinement. Methods: We will enroll 192 participants randomized to receive intervention components delivered via an audio recording that they will listen to prior to weekly in-lab physical activity sessions. Participants in the high dose conditions will also be instructed to listen to the audio recording 4 additional days each week. We will evaluate effects of the components on physical activity over 6 weeks in a 2 (EFT vs recent thinking) × 2 (PAI vs neutral imagery) × 2 (planning vs no planning) × 2 (dose: 5×/week vs 1×/week) full factorial randomized trial. Results: The National Cancer Institute funded this study (R21CA260360) on May 13, 2021. Participant recruitment began in February 2022. Data analysis will begin after the completion of data collection. Conclusions: The GeT Active study will result in a scalable, audio-recorded intervention that will accelerate progress toward the full development of guided thinking interventions to promote physical activity. Trial Registration: ClinicalTrials.gov NCT05235360; https://clinicaltrials.gov/ct2/show/NCT05235360 International Registered Report Identifier (IRRID): DERR1-10.2196/40908


  • Open Access

    Testing and Optimizing Guided Thinking Tasks to Promote Physical Activity: Protocol for a Randomized Factorial Trial (Preprint)

    by Austin S. Baldwin, Colin L. Lamb, Bree A. Geary, Alexis D. Mitchell, Chrystyna D. Kouros, Sara Levens, Laura E. Martin

    BACKGROUND Insufficient physical activity is associated with various health risks; however, most current physical activity interventions have critical barriers to scalability. Delivering interventions via technology and identifying active and inert components in early-phase development are ways to build more efficient and scalable interventions. We developed a novel intervention to promote physical activity that targets three brief guided thinking tasks (i.e., episodic future thinking [EFT], positive affective imagery [PAI], planning), separately and in combination, using brief audio-recordings. OBJECTIVE The aim of the GeT (Guided Thinking) Active study is to optimize a scalable guided thinking intervention to promote physical activity, using principles of the Multiphase Optimization Strategy (MOST). Mechanism-focused analyses will inform which components are optimal candidates for inclusion in an intervention package and which need refinement. METHODS We will enroll 192 participants randomized to receive intervention components delivered via an audio-recording that they will listen to prior to weekly in-lab physical activity sessions. Participants in the high dose conditions will also be instructed to listen to the audio-recording on four additional days during each week. We will evaluate effects of the components on physical activity over 6 weeks in a 2 (EFT vs. recent thinking) x 2 (PAI vs. neutral imagery) x 2 (Planning vs. no planning) x 2 (dose: 5x/week vs. 1x/week) full factorial randomized trial. RESULTS The National Cancer Institute funded this study (R21CA260360) on May 13, 2021. Participant recruitment began in February 2022. Data analysis will begin after the completion of data collection. CONCLUSIONS The GeT Active study will result in a scalable, audio-recorded intervention that will accelerate progress toward the full development of guided thinking interventions to promote physical activity. CLINICALTRIAL ClinicalTrials.gov Identifier: NCT05235360

  • Open Access

    The Effects of Positive Affect and Episodic Future Thinking on Temporal Discounting and Healthy Food Demand and Choice Among Overweight and Obese Individuals: Protocol for a Pilot 2×2 Factorial Randomized Controlled Study

    by Sara M Levens, Sara J Sagui-Henson, Meagan Padro, Laura E Martin, Elisa M Trucco, Nina A Cooperman, Austin S Baldwin, Angelos P Kassianos, Noreen D Mdege

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: Unhealthy behaviors, such as poor food choices, contribute to obesity and numerous negative health outcomes, including multiple types of cancer and cardiovascular and metabolic diseases. Despite known risks, roughly 75% of adults in America and England are not meeting fruit and vegetable intake recommendations. To promote healthy food choice and weight loss maintenance, diet interventions should build on the dual-system model to target both the regulation and reward mechanisms that guide eating behavior. Episodic future thinking (EFT) has been shown to strengthen regulation mechanisms by reducing unhealthy food choice and temporal discounting, a process of placing greater value on smaller immediate rewards over larger future rewards. However, these interventions do not target the reward mechanisms that could support healthy eating and strengthen the impact of EFT-anchored programs. Increasing positive affect (PosA) related to healthy food choices may target reward mechanisms by enhancing the rewarding effects of healthy eating. An intervention that increases self-regulation regarding unhealthy foods and the reward value of healthy foods is likely to have a greater impact on eating behavior compared to interventions focused on either process alone. Objective: Introduce a protocol that tests the independent and interactive effects of EFT and PosA on temporal discounting, food choice, and food demand in overweight and obese adults. Methods: This protocol describes a factorial, randomized, controlled pilot study protocol that employs a 2 (affective imagery: positive, neutral) x 2 (EFT: yes, no) design in which participants are randomized to one of four guided imagery intervention arms. One hundred and fifty-six eligible participants will complete two laboratory visits separated by one week. At visit 1 participants will complete surveys, listen to the audio guided imagery intervention, and complete temporal discounting, food demand, behavioral food choice tasks. At visit 2 participants will complete temporal discounting, food demand, behavioral food choice tasks and surveys. Participants will complete a daily food frequency questionnaire between visit 1 and 2. Analyses will compare primary outcome measures at baseline, post-intervention, and at follow-up across treatment arms. Secondary analyses will examine associations among changes in primary outcome measures and psychological (e.g., trait impulsivity, mindfulness) and behavioral health (e.g., physical activity, smoking and alcohol use) variables. Conclusions: Our research goal is to develop novel, theory-based interventions to promote and improve healthy decision-making and behaviors. The current study focuses on obesity and presents a protocol testing an intervention targeting regulation and reward mechanisms of eating behavior. Findings will advance decision-making research and have the potential to generate new neuroscience and psychological research to further understand these mechanisms and their interactions.


  • Long‐chain polyunsaturated fatty acid supplementation in the first year of life affects brain function, structure, and metabolism at age nine years

    by Rebecca J. Lepping, Robyn A. Honea, Laura E. Martin, Ke Liao, In‐Young Choi, Phil Lee, Vlad B. Papa, William M. Brooks, D. Jill Shaddy, Susan E. Carlson, et al.

    The present study sought to determine whether supplementation of long‐chain polyunsaturated fatty acids (LCPUFA) during the first year of life influenced brain function, structure, and metabolism at 9 years of age. Newborns were randomly assigned to consume formula containing either no LCPUFA (control) or formula with 0.64% of total fatty acids as arachidonic acid (ARA; 20:4n6) and variable amounts of docosahexaenoic acid (DHA; 22:6n3) (0.32%, 0.64%, or 0.96% of total fatty acids) from birth to 12 months. At age 9 years (±0.6), 42 children enrolled in a follow‐up multimodal magnetic resonance imaging (MRI) study including functional (fMRI, Flanker task), resting state (rsMRI), anatomic, and proton magnetic resonance spectroscopy (1H MRS). fMRI analysis using the Flanker task found that trials requiring greater inhibition elicited greater brain activation in LCPUFA‐supplemented children in anterior cingulate cortex (ACC) and parietal regions. rsMRI analysis showed that children in the 0.64% group exhibited greater connectivity between prefrontal and parietal regions compared to all other groups. In addition, voxel‐based analysis (VBM) revealed that the 0.32% and 0.64% groups had greater white matter volume in ACC and parietal regions compared to controls and the 0.96% group. Finally, 1H MRS data analysis identified that N‐acetylaspartate (NAA) and myo‐inositol (mI) were higher in LCPUFA groups compared to the control group. LCPUFA supplementation during infancy has lasting effects on brain structure, function, and neurochemical concentrations in regions associated with attention (parietal) and inhibition (ACC), as well as neurochemicals associated with neuronal integrity (NAA) and brain cell signaling (mI).


  • Open Access

    The Effects of Positive Affect and Episodic Future Thinking on Temporal Discounting and Healthy Food Demand and Choice Among Overweight and Obese Individuals: Protocol for a Pilot 2×2 Factorial Randomized Controlled Study (Preprint)

    by Sara M Levens, Sara J Sagui-Henson, Meagan Padro, Laura E Martin, Elisa M Trucco, Nina A Cooperman, Austin S Baldwin, Angelos P Kassianos, Noreen D Mdege

    BACKGROUND Unhealthy behaviors (eg, poor food choices) contribute to obesity and numerous negative health outcomes, including multiple types of cancer and cardiovascular and metabolic diseases. To promote healthy food choice, diet interventions should build on the dual-system model to target the regulation and reward mechanisms that guide eating behavior. Episodic future thinking (EFT) has been shown to strengthen regulation mechanisms by reducing unhealthy food choice and temporal discounting (TD), a process of placing greater value on smaller immediate rewards over larger future rewards. However, these interventions do not target the reward mechanisms that could support healthy eating and strengthen the impact of EFT-anchored programs. Increasing positive affect (PosA) related to healthy food choices may target reward mechanisms by enhancing the rewarding effects of healthy eating. An intervention that increases self-regulation regarding unhealthy foods and the reward value of healthy foods will likely have a greater impact on eating behavior compared with interventions focused on either process alone. OBJECTIVE This study aimed to introduce a protocol that tests the independent and interactive effects of EFT and PosA on TD, food choice, and food demand in overweight and obese adults. METHODS This protocol describes a factorial, randomized, controlled pilot study that employs a 2 (affective imagery: positive, neutral) by 2 (EFT: yes, no) design in which participants are randomized to 1 of 4 guided imagery intervention arms. In total, 156 eligible participants will complete 2 lab visits separated by 5 days. At visit 1, participants complete surveys; listen to the audio guided imagery intervention; and complete TD, food demand, and food choice tasks. At visit 2, participants complete TD, food demand, and food choice tasks and surveys. Participants complete a daily food frequency questionnaire between visits 1 and 2. Analyses will compare primary outcome measures at baseline, postintervention, and at follow-up across treatment arms. RESULTS Funding notification was received on April 27, 2017, and the protocol was approved by the institutional review board on October 6, 2017. Feasibility testing of the protocol was conducted from February 21, 2018, to April 18, 2018, among the first 32 participants. As no major protocol changes were required at the end of the feasibility phase, these 32 participants were included in the target sample of 156 participants. Recruitment, therefore, continued immediately after the feasibility phase. When this manuscript was submitted, 84 participants had completed the protocol. CONCLUSIONS Our research goal is to develop novel, theory-based interventions to promote and improve healthy decision-making and behaviors. The findings will advance decision-making research and have the potential to generate new neuroscience and psychological research to further understand these mechanisms and their interactions. CLINICALTRIAL ISRCTN Registry ISRCTN11704675; http://www.isrctn.com/ISRCTN11704675 (Archived by WebCite at http://www.webcitation.org/760ouOoKG) INTERNATIONAL REGISTERED REPOR DERR1-10.2196/12265

  • Adolescents' behavioral and neural responses to e‐cigarette advertising

    by Yvonnes Chen, Carina H. Fowler, Vlad B. Papa, Rebecca J. Lepping, Morgan G. Brucks, Andrew T. Fox, Laura E. Martin

    Although adolescents are a group heavily targeted by the e‐cigarette industry, research in cue‐reactivity has not previously examined adolescents' behavioral and neural responses to e‐cigarette advertising. This study addressed this gap through two experiments. In Experiment One, adult traditional cigarette smokers ( n = 41) and non‐smokers ( n = 41) answered questions about e‐cigarette and neutral advertising images. The 40 e‐cigarette advertising images that most increased desire to use the product were matched to 40 neutral advertising images with similar content. In Experiment Two, the 80 advertising images selected in Experiment One were presented to adolescents ( n = 30) during an functional magnetic resonance imaging brain scan. There was a range of traditional cigarette smoking across the sample with some adolescents engaging in daily smoking and others who had never smoked. Adolescents self‐reported that viewing the e‐cigarette advertising images increased their desire to smoke. Additionally, all participants regardless of smoking statuses showed significantly greater brain activation to e‐cigarette advertisements in areas associated with cognitive control (left middle frontal gyrus), reward (right medial frontal gyrus), visual processing/attention (left lingual gyrus/fusiform gyrus, right inferior parietal lobule, left posterior cingulate, left angular gyrus) and memory (right parahippocampus, left insula). Further, an exploratory analysis showed that compared with age‐matched non‐smokers ( n = 7), adolescent smokers ( n = 7) displayed significantly greater neural activation to e‐cigarette advertising images in the left inferior temporal gyrus/fusiform gyrus, compared with their responses to neutral advertising images. Overall, participants' brain responses to e‐cigarette advertisements suggest a need to further investigate the long‐run impact of e‐cigarette advertising on adolescents.


  • Open Access

    Comparison of obese adults with poor versus good sleep quality during a functional neuroimaging delay discounting task: A pilot study

    by Laura E. Martin, Lauren Pollack, Ashley McCune, Erica Schulte, Cary R. Savage, Jennifer D. Lundgren